Skip to content
Open access

Serum Levels of the Proinflammatory Cytokines IL-6, IL-16, IL-18, and IL-36 in Patients with Multiple Sclerosis from the Western Region of Saudi Arabia: Associations with Disease Duration and Disability

Sep 2026 · Neurology International · Vol 18 · 0 citations · 38 references
Medicine

TL;DR

IL-6 alone showed a modest, unadjusted association with disability, supporting its evaluation as a candidate biomarker in larger, longitudinal, covariate-adjusted cohorts, and these findings are hypothesis-generating and should not be interpreted as evidence of independent or clinically actionable biomarker utility.

Abstract

Background: Systemic inflammation contributes to the pathobiology of multiple sclerosis (MS), yet serum biomarker data from Middle Eastern populations remain limited. This study evaluated serum levels of IL-6, IL-16, IL-18, and IL-36 in Saudi adults with MS compared with matched healthy controls and examined associations with disease duration, phenotype, treatment, and disability. Methods: This single-center, cross-sectional, matched case–control study enrolled 26 MS patients and 26 age- and sex-matched controls. Serum cytokines were measured by ELISA. Disability was assessed using EDSS and the Timed 25-Foot Walk (T25FW). Matched comparisons used Wilcoxon signed-rank tests; subgroup comparisons used Wilcoxon rank-sum or Kruskal–Wallis tests; associations used Spearman’s correlation. Results: No correction for multiple comparisons was applied given the exploratory design. All four interleukins were higher in MS patients than in controls (p < 0.001). Age correlated with EDSS (r = 0.573, p = 0.002) and T25FW (r = 0.464, p = 0.014). Only IL-6 showed a notable correlation with disability, with T25FW (r = 0.53, p = 0.008) and, weaker, EDSS (r = 0.38, p = 0.052); IL-18 showed a weak, non-significant correlation with T25FW (r = 0.35, p = 0.126); IL-16 and IL-36 showed no relevant associations. IL-16 was higher in newly diagnosed than in long-standing cases (p = 0.012); no differences by phenotype or treatment were observed for any marker. Conclusions: Serum IL-6, IL-16, IL-18, and IL-36 were elevated in Saudi MS patients versus controls. IL-6 alone showed a modest, unadjusted association with disability, supporting its evaluation as a candidate biomarker in larger, longitudinal, covariate-adjusted cohorts. These findings are hypothesis-generating and should not be interpreted as evidence of independent or clinically actionable biomarker utility.

Read PDF

Similar papers

Open access Oct 2026

Patterns of Mutual Associations Within the IL-12 Cytokine Family in Systemic Sclerosis Patients: A Pilot Study

Objectives: This study aimed to investigate the associations among cytokines of the IL-12 family in patients with systemic sclerosis (SSc) and to evaluate their relationships with the pro-inflammatory cytokines TNF-α and IL-6, the latent form of TGF-β1 (LAP-bound, without prior sample activation), clinical parameters,...

P. Kotyla, Olga Gumkowska-Sroka, A. Owczarek et al. · 0 citations
Open access Oct 2026

EVALUATION OF SERUM IL-6, IL-17, AND TNF- A AS POTENTIAL IMMUNOLOGICAL BIOMARKERS IN PATIENTS WITH VITILIGO

Background: Vitiligo is a chronic immune-mediated depigmenting disorder accompanied by both hyperactive inflammatory and autoimmunity pathways. Objective: To evaluate the serum levels of interleukin-6 (IL-6), interleukin-17 (IL-17), and tumor necrosis factor-A (TNF-A) in vitiligo patients, determine the correlation of...

Saleem Abbas Ajzan · 0 citations
Open access 2026

INCREASED SERUM LEVELS OF INTERLEUKINS IL-6, IL-10, IL-17, AND IL-18 AS PREDICTORS OF ADVERSE OUTCOMES IN COVID-19-RELATED ACUTE RESPIRATORY DISTRESS SYNDROME

Objective: The study evaluated the dynamics of interleukin (IL-6, IL-10, IL-17, and IL-18) levels in the serum of patients with acute respiratory distress syndrome (ARDS) during severe and critical COVID-19 to determine their prognostic significance. Methods: Seventy participants were examined: 50 patients with COVID-1...

B. Shaposhnikov, A. N. Obedin, M. V. Golubeva et al. · 0 citations
Open access Sep 2026

Diagnostic Value of Serum Interleukin-9 in Patients with Type 2 Diabetes Mellitus: A Case-Control Study from Basrah, Iraq

Background: Type 2 diabetes mellitus (T2DM) is increasingly recognized as a chronic low-grade inflammatory disorder in which immune dysregulation contributes to insulin resistance and disease progression. Interleukin-9 (IL-9), a pleiotropic cytokine of the common γ-chain family, has recently been implicated in metaboli...

Fatima Tariq, I. S. Mahmood, H. Alidrisi · 0 citations
Open access Sep 2026

Evaluation of Th17 Cells, CD4+ T Cells, IL-17 and IL-22 in Streptococcus Pyogenes-Associated Psoriasis: An Integrated Immunological Study

Assessment of circulating Th17 and CD4+ T-cell populations and serum levels of IL-17 and IL-22 in psoriasis patients shows integration of environmental factors and microbial co-factors must be incorporated into cellular and cytokine immune response profiles in order to better understand psoriasis.

Heyam Qaid Mohammed Al-Kenani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.